Wynn Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$380K Buy
4,858
+225
+5% +$18.2K 0.17% 85
2026
Q1
$401K Buy
4,633
+139
+3% +$13.3K 0.21% 78
2025
Q4
$432K Sell
4,494
-145
-3% -$14.1K 0.21% 75
2025
Q3
$442K Buy
4,639
+110
+2% +$10.1K 0.21% 78
2025
Q2
$395K Buy
4,529
+31
+0.7% +$2.63K 0.21% 81
2025
Q1
$404K Buy
4,498
+180
+4% +$16.1K 0.24% 79
2024
Q4
$345K Buy
4,318
+397
+10% +$34.4K 0.22% 85
2024
Q3
$353K Buy
3,921
+640
+20% +$53.8K 0.23% 87
2024
Q2
$258K Buy
3,281
+431
+15% +$35.3K 0.19% 93
2024
Q1
$248K Buy
2,850
+400
+16% +$34.1K 0.19% 92
2023
Q4
$202K Buy
+2,450
New +$187K 0.16% 101

Other funds holding MDT

Wynn Capital's MDT Position: Q2 2026 in Review

Wynn Capital increased its Medtronic (MDT) stake by 4.9% in Q2 2026, buying an estimated $18.2K and bringing the position to 4,858 shares worth $380K. The position accounts for 0.17% of the portfolio, ranked #85.

Wynn Capital first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $442K in Q3 2025. 949 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Wynn Capital held 4,858 shares of Medtronic worth $380K as of Q2 2026.
  • Wynn Capital bought 225 Medtronic shares in Q2 2026, an estimated $18.2K.
  • Medtronic made up 0.17% of Wynn Capital's portfolio in Q2 2026, its #85 holding.
  • Wynn Capital first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • Wynn Capital's Medtronic position peaked at $442K in Q3 2025.
  • 949 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Wynn Capital's 13F filing for Q2 2026, filed 8 Jul 2026.